Evidence map›Paper›PMID 42278645›Full record

ArticleInternational journal of molecular sciences2026

Study of

Mengmeng Wang, Jingming Zou, Qi Zhang, Xianxiang Bai, Si Wu, Yawei Hu, Xiaoyan Han, Na Han, Bin Xiao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengmeng WangDevelopment and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
Jingming ZouGeneral Clinical Research Center, Ordos School of Clinical Medicine, Inner Mongolia Medical University, Ordos 017000, China.
Qi ZhangDevelopment and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xianxiang BaiGeneral Clinical Research Center, Ordos School of Clinical Medicine, Inner Mongolia Medical University, Ordos 017000, China.
Si WuGeneral Clinical Research Center, Ordos School of Clinical Medicine, Inner Mongolia Medical University, Ordos 017000, China.
Yawei HuGeneral Clinical Research Center, Ordos School of Clinical Medicine, Inner Mongolia Medical University, Ordos 017000, China.
Xiaoyan HanGeneral Clinical Research Center, Ordos School of Clinical Medicine, Inner Mongolia Medical University, Ordos 017000, China.
Na HanDevelopment and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
Bin XiaoDevelopment and Utilization Key Laboratory of Northeast Plant Materials, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.

Funding

National Natural Science Foundation of China 82260822The Key Research and Development Program of Ordos 2022YY010, YF20232312the Natural Science Foundation of Inner Mongolia 2024QN08026the Youth Top-notch Talent Foundation of Inner Mongolia [2024] No. 3
6 · The paper itself

Abstract

Allergic rhinitis (AR) is one of the most prevalent allergic disorders worldwide. Current pharmacological treatments are often limited by suboptimal efficacy and notable adverse effects. Herbal medicines, with their multi-component and multi-target therapeutic characteristics, have attracted increasing attention.

Indexed as

ArtemisiaCell DegranulationMast CellsPlant ExtractsRhinitis, AllergicAnimalsMiceMolecular Docking SimulationMolecular Dynamics SimulationNetwork PharmacologySignal TransductionPlant Extractsallergic rhinitisArtemisia ordosica Krasch.mast cell degranulationmolecular dockingnetwork pharmacology

Identifiers

PMID42278645
PMCPMC13257801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.